Gastric perforation by MALT lymphoma. Case report  by López-Zamudio, José et al.
Cirugía y Cirujanos. 2015;83(3):217--221
www.amc.org.mx www.elsevier.es/circir
CIRUGÍA  y  CIRUJANOS
Órgano de difusión científica de la Academia Mexicana de Cirugía
Fundada en 1933
CLINICAL CASE
Gastric  perforation  by  MALT  lymphoma.  Case  report
José López-Zamudioa, Luis Ricardo Ramírez-Gonzáleza, Julia Nún˜ez-Márquezb,
Clotilde  Fuentes Orozcoc, Alejandro González Ojedac, Karla Lisseth Leonher-Ruezgaa,∗
a Unidad  Médica  de  Alta  Especialidad,  Departamento  de  Cirugía  General,  Hospital  de  Especialidades  del  Centro  Médico  Nacional
de Occidente.  Instituto  Mexicano  del  Seguro  Social  (IMSS),  Guadalajara,  Jalisco,  México
b Departamento  de  Patología,  Hospital  General  Regional  No.  45.  IMSS,  Guadalajara,  Jalisco,  México
c Unidad  de  Investigación  en  Epidemiología  Clínica,  Hospital  de  Especialidades  del  Centro  Médico  Nacional  de  Occidente.  IMSS,
Guadalajara, Jalisco,  México
Received  12  May  2014;  accepted  26  September  2014
KEYWORDS
Gastric  lymphoma;
Mucosa  associated
lymphoid  tissue
lymphoma;
Gastric  neoplasms
Abstract
Background:  Gastric  non-Hodgkin  lymphoma  is  a  rare  tumour  that  represents  approximately  7%
of all  stomach  cancers  and  2%  of  all  lymphomas.  The  most  frequent  location  of  gastric  MALT
(mucosa associated  lymphoid  tissue)  lymphomas  is  in  the  antrum  in  41%  of  the  cases,  and  33%
can be  multifocal.  The  risk  of  spontaneous  perforation  of  a  gastric  MALT  lymphoma  is  4--10%.
Clinical  case: A 24-year-old  male  patient  carrying  the  Human  Immunodeﬁciency  Virus,  who
began with  signs  and  symptoms  of  acute  abdomen  and  fever  72  h  before  arriving  in  the  emer-
gency room.  A  computed  tomography  was  performed  that  showed  free  ﬂuid  in  the  cavity,  and
gastric wall  thickening.  The  patient  underwent  a  laparotomy,  ﬁnding  absence  of  the  ante-
rior wall  of  the  stomach,  sealed  with  the  left  lobe  of  the  liver,  colon  and  omentum.  Total
gastrectomy,  with  oesophagosty  and  jejunostomy  tube,  was  performed.
Conclusions:  Gastric  perforation  secondary  to  a  MALT  lymphoma  is  rare,  with  high  mortality.
There is  limited  information  reported  of  this  complication  and  should  be  highly  suspected  in
order to  provide  appropriate  treatment  for  a  complication  of  this  type.
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Perforación  gástrica  por  linfoma  MALT.  Reporte  de  caso
Resumen
Antecedentes:  El  linfoma  gástrico  no  Hodking  es  un  tumor  poco  frecuente  el  cual  representa
aproximadamente  el  7%  de  todas  las  neoplasias  malignas  del  estómago  y  2%  de  todos  los  linfo-
mas. Siendo  la  localización  gástrica  la  más  frecuente  de  los  linfomas  MALT  (linfoma  de  tejido
linfoide asociado  a  mucosa),  presentándose  con  mayor  frecuencia  en  el  antro  gástrico  en  el
41% de  los  casos,  y  el  33%  puede  ser  multifocal.  El  riesgo  de  perforación  espontánea  por  un
linfoma MALT  gástrico  es  del  4-10%.  El  objetivo  de  este  artículo  es  presentar  el  caso  de  una
complicación  rara  en  un  paciente  inmunosuprimido,  y  hacer  una  revisión  del  tema.
Caso clínico: Paciente  masculino  de  24  an˜os  portador  de  virus  de  la  inmunodeﬁciencia  humana,
el cual  inició  con  signos  y  síntomas  de  abdomen  agudo  de  72  horas  de  evolución  y ﬁebre.  Acude
a Urgencias  en  donde  se  le  realiza  tomografía  de  abdomen  la  cual  muestra  líquido  libre  en
cavidad, y  engrosamiento  de  paredes  gástricas.  Se  somete  a  laparotomía,  encontrando  ausencia
de pared  anterior  de  estómago  sellada  con  lóbulo  izquierdo  del  hígado,  colon  y  epiplón.  Se
realiza gastrectomía  total  con  esofagostoma  y  sonda  de  yeyunostomía.
Conclusiones:  La  perforación  gástrica  por  un  linfoma  MALT  es  muy  rara  con  una  alta  mortalidad,
hay poca  información  reportada  sobre  esta  complicación,  se  debe  de  tener  una  alta  sospecha
para poder  ofrecer  un  tratamiento  oportuno  para  una  complicación  de  este  tipo.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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astric  mucosa  associated  lymphoid  tissue  lymphoma  (MALT)
s  a  rare  disease,1 described  for  the  ﬁrst  time  in  1983
y  Isaacson  and  Wright2;  it  is  classiﬁed  as  non-Hodgkin
-cells,  extranodal  lymphomas  and  within  marginal  zone
ymphomas,  which  means  it  can  disseminate  to  lymph  nodes
nd  other  organs  during  its  progression.1,2 This  represents
pproximately  7%  of  all  stomach  malignant  neoplasms,  and
%  of  all  lymphomas.2 Gastric  location  is  the  most  frequent
ocation  of  MALT  lymphomas,  with  a  higher  frequency  in  the
astric  area  in  41%  of  cases,  and  may  be  multifocal  in  33%
f  cases.3
The  most  frequent  age  of  presentation  is  after  50  years
f  age,  more  often  in  men  than  in  women,  1.7:1.  At  the
ime  of  diagnosis  it  is  a  low  grade  tumour  in  70--85%  of
ases.1,4
The  risk  of  spontaneous  perforation  caused  by  gas-
ric  MALT  is  4--10%,  may  be  presented  spontaneously  as
n  emergency  or  as  a  complication  of  quimio  or  radio-
herapy;  but  a  complete  absence  of  the  anterior  wall  of
he  stomach,  as  in  this  case  report,  is  an  even  rarer
resentation.4,5
There  is  a  close  relation  between  the  infection  caused
y  Helicobacter  pylori  (H.  pylori) and  the  development  of
astric  MALT  lymphoma,  as  shown  by  various  studies.
The  risk  of  gastric  perforation  may  be  presented  spon-
aneously  as  an  emergency  or  as  a  complication  of  quimio
r  radiotherapy6;  but  the  complete  absence  of  the  anterior
all  of  the  stomach  as  in  the  case  of  our  patient  is  rare,  and
herefore  our  goal  is  to  perform  a  review  of  the  few  reports
f  this  complication,  and  the  correct  management  of  this
athology.
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Alinical case
 male  patient,  24  years  old,  relevant  history  as  HIV  car-
ier  from  birth  controlled  by  the  Infectology  service  with
ast  HIV  viral  load  of  163  copies/ml,  CD4  19cel/AL  under
reatment  with  tenofovir/entricitabine  and  efavirenz,  pul-
onary  tuberculosis  for  3  years,  denies  other  diseases  or
rior  surgeries.
The  current  condition  began  72  h prior  to  admission  into
he  Casualty  department  with  sudden  onset  abdominal  pain
n  the  epigastrium  with  irradiation  to  the  dorsum,  burning
ype,  constant  and  incapacitating,  EVA  9/10,  with  nausea
ut  no  vomits,  non-quantiﬁed  fever,  no  self-medication,
ith  2  days  of  pain  until  attending  Casualty  because  there
as  no  improvement.
Physical  examination:  blood  pressure  110/70  mmHg,
eart  rate  117  per  minute,  respiratory  rate  18  per  minute,
emperature  37.5 ◦C.  Cachectic  patient,  pale  teguments,
ehydrated,  no  neurological  impairment  with  appearance
f  pain,  oriented  in  time  and  space,  rhythmic  heart  area,
achycardia  with  no  murmurs  or  adventitious  sounds,  well
entilated  lung  ﬁelds  with  no  rales  or  wheezes.  Abdomen
t  auscultation  with  decreased  peristaltic  noises,  tympanic
n  percussion,  with  involuntary  rigidity,  pain  on  superﬁcial
alpation  in  all  quadrants,  mass  palpated  in  epigastrium  and
esogastrium,  positive  rebound,  with  clear  data  of  periton-
al  irritation.
Laboratory  results  upon  admission:  leukocytes  4.0
housand/Ul,  haemoglobin  6.2  g/dl,  haematocrit  21.7%,
latelets  254  thousand/Ul,  neutrophils  84.9%,  lymphocytes
.8%,  TP  12.9,  glucose  81  mg/dl,  creatinine  0.9  mg/dl,  K
.5  mmol/l,  Na  122  mmol/l,  lactic  dehydrogenase  493  U/l.
rterial  blood  gas:  pH  7.35,  PCO2 29,  PO2 76,  HCO3 17,
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Figure  1  Simple  computed  tomography  of  the  abdomen  with
Figure  3  Surgical  piece:  in  the  macroscopic  aspect,  the  thick-
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clinical  manifestations  in  its  initial  states,  and  may  even
be  asymptomatic;  many  times  confused  with  gastric  can-
cer;  usually  causes  a  dyspeptic  condition,  with  prevalenceabundant  free  ﬂuid  in  cavity,  thickened  gastric  walls  and  free
air in  cavity.
CO2 18,  EB-6.1,  SatO2 95.5%  with  no  supplementary  oxygen
support.
The  assessment  using  the  APACHE  II  scale  proved  to  be  15
points  with  25%  mortality.
A simple  abdomen  tomography  was  taken,  showing  left
pleura  thickening  with  a  small  effusion,  abdomen  with  free
ﬂuid  in  all  the  abdominal  cavity,  and  stomach  with  thickened
walls  where  the  left  lobe  of  the  liver  adhered  to  the  stomach
(Fig.  1).
An  emergency  laparotomy  was  performed,  where  600  cc
of  inﬂammatory  free  ﬂuid  was  found  in  the  cavity,  with  no
data  of  active  bleeding;  a  mass  involving  the  liver,  stom-
ach  and  colon;  absence  of  anterior  gastric  wall  found  upon
dissection;  from  3  cm  below  the  oesophagogastric  junction
up  to  the  pylorus,  the  folds  of  the  gastric  mucosa  were
thickened  and  indurated;  inﬂammatory  adenopathies  in  the
greater  and  lesser  curvature  of  approximately  0.5  cm;  and
transverse  colon  dilated  approximately  5  cm  of  diameter
(Fig.  2).  With  these  ﬁndings,  it  is  decided  to  perform  a  full
gastrectomy  with  oesophagostoma  plus  placing  of  jejunos-
tomy  tube.
The  patient  was  transferred  to  the  Intensive  Care  Unit
with  pressor  amines  support,  with  multiple  organ  failure
secondary  to  abdominal  sepsis,  and  died  24  hours  later.Later,  a  peritoneal  ﬂuid  culture  was  received  where  yeast
Gram  is  reported,  low  levels  of  polymorphonuclear  cells
and  Candida  albicans.  Cytochemical  examination  of  unclear
Figure  2  Image  where  there  was  a  mass  in  the  liver,  colon
and omentum  already  dissected,  showing  the  absence  of  the
anterior  stomach  wall.
F
tning  of  the  mucosa,  stony  appearance  and  absence  of  anterior
astric wall  are  visible.
eritoneal  ﬂuid,  leukocytes  10.710  mm,3 polymorphonu-
lear  cells  90%  with  crenocytes,  piocytes,  bacteria  and
ononuclear  cells  10%.
The  histopathological  result  of  the  piece  reported  a  histo-
ogical  image  with  high  grade  malignant  lymphoproliferative
esion  in  relation  to  MALT  lymphoma,  positive  immunohisto-
hemistry  for  CD20++,  CD21+++,  and  CD35++,  negative  for
D10,  and  CD5  (Figs.  3  and  4).
iscussion
pontaneous  gastric  perforation  secondary  to  lymphoma  is  a
are  complication,  and  we  found  only  one  case  report  of  this
ype  of  complication,  reported  by  Ayako  and  Kitsukawa,7
here  the  initial  presentation  was  through  gastric  ulcers
s  a  consequence  of  the  tumour;  in  our  case  the  patient
ever  presented  gastric  symptomatology,  and  never  had  an
ndoscopy  during  his  lifetime,  which  made  it  very  compli-
ated  to  make  an  earlier  diagnosis.
Gastric  MALT  lymphoma  is  a  neoplasia  producing  scarceigure  4  Surgical  piece  of  the  gastrectomy:  thickening  of  gas-
ric folds  and  absence  of  the  anterior  gastric  wall  are  visible.
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f  epigastric  pain,  with  or  without  ulcerous  rhythm,  feeling
f  fullness,  nausea  and  vomiting.  Advanced  tumours  produce
 condition  similar  to  gastric  carcinoma,  with  weight  loss,
atigue,  anorexia,  digestive  bleeding,  and  in  10--20%  of  cases
t  is  possible  to  feel  an  abdominal  tumour.1,2,4,7
The  diagnosis  of  MALT  lymphoma  was  based  on  the
astroscopy,  taking  biopsies,  and  a  characteristic  but  non-
athognomonic  ﬁnding  of  MALT  lymphomas  with  thickened
astric  walls,  which  were  clearly  visible  in  the  tomography
aken  on  admission.  Also,  we  observed  the  presence  of  ulcer-
tions,  with  thickened  folds  and/or  irregular  or  polypoid
umours.  The  ﬁnding  of  these  lesions  next  to  multiple,  star-
ike  conﬁguration  ulcers  and  sometimes  conﬂuent  ulcers
which  may  even  pass  the  pylorus  and  affect  the  duode-
um)  suggests  lymphomatose  lesion.  Even  when  there  is  just
 suspicion  of  the  existence  of  MALT  lymphoma,  numerous
amples  should  be  taken  from  the  antrum  to  the  fornix,
apping  all  the  gastric  mucosa.1,2,8
The  histological  diagnosis  is  shown  through  immunohis-
ochemistry  techniques,  Southern  Blot  and  PCR  to  detect
onoclonality  of  B-lymphocytes,  speciﬁcally  in  differential
iagnosis  with  pseudolymphomas.  Tumour  cells  are  small-
edium  sized  B-lymphocytes,  with  non-abundant  cytoplasm
nd  irregular-shaped  nuclei,  called  centrocytoid  lympho-
ytes,  and  small  or  monocytoid-type  lymphocytes  are  less
requent;  in  one  lesion  there  may  be  a  clear  prevalence  of
ne  cell  shape,  or  several  shapes  may  coexist.  The  pres-
nce  of  lymphoepithelial  lesion  is  considered  as  the  most
haracteristic  morphological  feature  of  MALT  lymphoma,
hich  consists  of  the  invasion  of  the  crypt  by  aggregate
entrocitoid  lymphocytes.  Other  histological  ﬁndings  are  the
oderate  atypical  cell  of  tumour  lymphocites  and  the  pres-
nce  of  lymphocites  with  Dutcher  bodies,  although  their
bsence  does  not  rule  out  the  diagnosis.1,3,4,8
Immunohistological  studies  show  the  following  as  pos-
tive:  CD20,  CD21,  CD35  and  IgM,  and  the  following  as
egative:  CD5,  CD10,  CD23  and  cyclin  D1(-).  The  presence
f  monoclonality  does  not  equal  malignancy,  and  there  may
e  monoclonality  without  lymphoma  or  persistence  thereof
ome  time  after  the  tumour  has  disappeared.1,2,4,8
The  division  into  low  and  high  grade  lymphomas  is  based
n  the  proportion  of  blast  cells  in  the  lesion.  The  classiﬁca-
ion  of  the  tumour  into  high  or  low  grade  is  important,  since
he  high  grade  represents  a  more  aggressive  clinical  condi-
ion  and  a  worse  prognosis.  The  histological  diagnosis  of  the
rade  can  be  difﬁcult  in  certain  patients,  since  both  grades
an  coexist  in  the  same  lesion  or  different  multifocal  lesions,
aving  gone  through  the  evolutional  transformation  of  low
nd  high  grade  in  MALT  lymphomas.  It  is  considered  that
he  presence  of  islets  of  more  than  20  transformed  cells,
r  a  proportion  above  15--20%  of  high  grade  cells,  is  clini-
ally  relevant.  In  certain  high  grade  lymphomas  there  are
o  signs  of  low  grade  lesion,  and  therefore  these  tumours
ay  be  considered  high  grade  ‘‘de  novo’’.  However,  this
nformation  lacks  prognosis  value  because  there  are  no  clin-
cal  differences  in  lymphomas  progressing  from  low  to  high
rade.1,2,8
There  are  several  therapeutic  possibilities  for  gastric
ALT  lymphomas,  including:  treatment  to  eradicate  the
nfection  by  H.  pylori; surgical  treatment;  non-surgical
ncological  treatment  with  quimio  and/or  radiotherapy.
hese  modalities  of  treatment  can  supplement  each  other.  In
d
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he  case  of  low  grade  lymphomas,  no  signiﬁcant  differences
ave  been  found  in  survival  after  treatment  for  eradication,
hether  surgery,  chemotherapy,  or  surgery  plus  chemother-
py  or  radiotherapy.1,2,9 The  survival  of  patients  operated
or  healing  purposes  up  to  5  years  is  93.7%  in  stage  I,  stage  II
5%  and  stage  III  25%.1,6,9 When  the  surgery  is  palliative,  the
urvival  is  37.1%  up  to  5  years,  while  survival  of  operated
atients  with  negative  lymph  nodes  is  92.3%  up  to  5  years,
nd  with  positive  lymph  nodes  it  is  41.3%  and  in  both  up  to
 years.1,6,9
In  low  grade  tumours,  it  has  been  shown  that  eradica-
ion  of  H.  pylori  leads  to  tumour  remission,  by  interrupting
he  immunological  stimulus  which  maintains  its  growth.  It  is
pparently  permanent,  but  conﬁrmed  up  to  5  years  with  no
ata  of  tumour  activity.
The  recommended  ﬁrst  line  treatment  for  clinical  stages  I
nd  II  is  to  treat  the  infection  by  H.  pylori, which  implies  the
ombination  of  any  inhibitor  of  the  proton  bombs  together
ith  amoxicillin  and  clarithromycin,  replacing  the  ﬁrst  one
ith  metronidazole  and,  in  case  of  allergy  to  the  former,  it
an  be  replaced  with  metronidazole.  Control  of  the  infec-
ion  for  H.  pylori  is  made  via  endoscopy;  if  it  is  conﬁrmed
hat  there  is  still  H.  pylori  infection  or  the  patient  continues
ith  symptoms  and  is  negative  for  H.  pylori, radiotherapy
hould  be  considered,  or  rituximab  if  radiotherapy  is  con-
raindicated.
For  clinical  stages  III  and  IV  where  the  patient  presents
leeding,  symptomatology,  advanced  disease,  affection
f  an  organ  and  shows  data  of  progression  of  the  dis-
ase,  if  there  is  any  of  the  above,  management  with
mmunological  therapy,  chemotherapy  or  locoregional  radio-
herapy  is  indicated.6,9 The  most  used  chemotherapy
chemes  are  bendamustine  plus  rituximab,  R-CHOP  (rit-
ximab,  cyclophosphamide,  doxorubicin,  vincristine  and
rednisone),  and  RCVP  (rituximab,  cyclophosphamide,  vin-
ristine  and  prednisone).1,6,9
Until  recently,  surgical  resection  was  the  treatment  used
or  maltoma.  Currently  the  indication  of  the  surgery  would
e  conﬁrmed  failure  of  the  treatment  for  eradication  or  high
rade  lymphoma,  limited  to  the  stomach  walls.  Although  the
esults  of  gastric  surgery  are  still  good,  with  mortality  lower
han  3%,  the  ideal  is  to  use  non-surgical  treatments.
Indications  of  emergency  surgery  for  a  MALT  lymphoma
re  perforation  with  an  incidence  of  4--10%,  pyloric  obstruc-
ion,  and  in  some  cases  haemorrhage  with  a  prevalence  of
9%,7,9 the  latter  being  the  most  frequent.  Spontaneous  gas-
ric  perforation  represents  a  very  serious  complication  with
igh  mortality.1,8,9
The  clinical  stage  is  the  main  prognosis  factor.  It  is  also
aid  that  tumours  smaller  than  5  cm  permit  100%  survival  up
o  5  years,  while  if  they  are  more  than  10  cm,  the  survival
ate  is  only  20%.9--11
onclusions
ALT  lymphoma  represents  50%  of  gastric  lymphomas  and  is
eveloped  secondary  to  an  infection  by  H.  pylori  as  a  result
f  chronic  gastritis.  However,  in  our  case  the  patient  denied
istory  of  acid  peptic  disease.  Finally,  the  patient  began  with
n  important  gastric  perforation,  which  is  one  of  the  rarest
1Gastric  perforation  by  MALT  lymphoma  
and  most  lethal  complications,  which  is  why  we  decided  to
report  this  case.
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